Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α

被引：0
|
作者：
Tromm, A
Greving, I
Hueppe, D
机构：
[1] BG Clinen BERGMANNSHEIL, Bochum, Germany
[2] Ruhr Univ Bochum, D-4630 Bochum, Germany
[3] Gastroemterp Fachpraxis, Herne, Germany
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G3621
引用
收藏
页码：A834 / A834
页数：1
相关论文
共 50 条
  • [21] Triple antiviral re-therapy for chronic hepatitis C with interferon-α, ribavirin and amantadine in nonresponders to interferon-α and ribavirin
    Zilly, M
    Lingenauber, C
    Desch, S
    Väth, T
    Klinker, H
    Langmann, P
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2002, 7 (04) : 149 - 154
  • [22] Ribavirin followed by alpha interferon retreatment in relapsers and in non-responders to alpha interferon for chronic hepatitis C
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Bellati, G
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P99 - P99
  • [23] Induction therapy with interferon-α 2b associated to Ribavirin and Ketoprofen in patients with chronic hepatitis C non-responders to interferon.: A pilot study.
    Munoz, AE
    Levi, DV
    Miguez, CD
    Cisterna, D
    Terg, RA
    HEPATOLOGY, 2001, 34 (04) : 589A - 589A
  • [24] Efficacy of interferon plus ribavirin in chronic hepatitis C patients non responders to interferon alone
    Picciotto, A
    Campo, N
    Torre, F
    Brizzolara, R
    Sinelli, N
    Celle, G
    HEPATOLOGY, 1998, 28 (04) : 479A - 479A
  • [25] Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia
    Sato A.
    Yamauchi M.
    Yamada T.
    Kumano R.
    Adachi K.
    Ishii T.
    Hayashi M.
    Kumon D.
    Clinical Journal of Gastroenterology, 2014, 7 (4) : 355 - 360
  • [26] Retreatment with interferon-α at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients
    Okanoue, T
    Daimon, Y
    Kirishima, T
    Ohnishi, N
    Nakamura, H
    Nagao, Y
    Minami, M
    Itoh, Y
    HEPATOLOGY RESEARCH, 2001, 20 (03) : 348 - 358
  • [27] Leukocyte interferon-α and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon
    Adinolfi, Luigi E.
    Durante-Mangoni, Emanuele
    Salzillo, Marta
    Marrone, Aldo
    Tripodi, Marie-Francoise
    Restivo, Luciano
    Merola, Antonietta
    Zampino, Rosa
    Ruggiero, Giuseppe
    INTERNAL AND EMERGENCY MEDICINE, 2009, 4 (06) : 485 - 490
  • [28] Leukocyte interferon-α and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon
    Luigi E. Adinolfi
    Emanuele Durante-Mangoni
    Marta Salzillo
    Aldo Marrone
    Marie-Francoise Tripodi
    Luciano Restivo
    Antonietta Merola
    Rosa Zampino
    Giuseppe Ruggiero
    Internal and Emergency Medicine, 2009, 4 : 485 - 490
  • [29] A comparison of combination therapy with interferon and ribavirin vs interferon and amantadine in interferon non-responders with chronic hepatitis C.
    Khalili, M
    Olmeda, M
    Denham, CB
    Perrillo, RP
    HEPATOLOGY, 1998, 28 (04) : 169A - 169A
  • [30] Interferon-gamma with interferon-alpha and ribavirin for hepatitis C non-responders
    Raza, S.
    Abbas, Z.
    Jafri, W.
    Hameed, S.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 44 - 44
12345